ZP3 and cancer: While the enriched expression of ZP3 in cancer versus normal tissue provides a therapeutic opportunity, whether ZP3 is secreted from cancer cells or not is an important strategic determinant for the development of a cancer immunotherapy based on active or passive immunization.